1. Home
  2. PRPH

PRPH

ProPhase Labs Inc. (DE)

Logo ProPhase Labs Inc. (DE)

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

Founded: 1989 Country:
United States
United States
Employees: 113 City: NEW YORK
Market Cap: 98.2M IPO Year: 1997
Target Price: $11.00 AVG Volume (30 days): 49.7K
Analyst Decision: Strong Buy Number of Analysts: 1
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.98 EPS Growth: N/A
52 Week Low/High: $4.05 - $9.94 Next Earning Date: 05-09-2024
Revenue: $44,384,000 Revenue Growth: -63.81%
Revenue Growth (this year): -49.44% Revenue Growth (next year): 495.45%

Share on Social Networks: